Oncology Pharma Inc.

Today, ONPH trades at 0.0400 USD.

For broader market analysis, dive into the technicals on the Oncology Pharma Inc. stock price chart and read the latest ONPH news:
– Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development
– Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Markets don't sleep, here's what's going on with ONPH at the moment:
– Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development
– Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

See more updates in real-time with our News Flow.

ONPH stock is 25.00% volatile and has beta coefficient of −31.96.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like ONPH are typically less volatile than smaller companies

Track every detail on Oncology Pharma Inc. stock chart and check out the list of the most volatile stocks — is Oncology Pharma Inc. there?

To understand the ONPH stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −11.11%
– 1 week — 0.00%
– 1 month — +33.33%

ONPH all-time low was 0.000001 USD (Nov 8, 2023), and its highest price is 375,000.0000 USD (Aug 16, 2013). Find more dynamics in the Stock Heatmap and on the Oncology Pharma Inc. stock chart.

Oncology Pharma Inc. market capitalization is ‪1.10 M‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Oncology Pharma Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Oncology Pharma Inc. stacks up against other companies

Investing in Oncology Pharma Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Oncology Pharma Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our ONPH technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.

Oncology Pharma Inc. stock ticker depends on the exchange where it’s listed. On the OTC, its primary exchange, Oncology Pharma Inc. stocks trade under the symbol ONPH.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.

Yes, you can track Oncology Pharma Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.

No, Oncology Pharma Inc. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends